Compare Crocs, Inc. (CROX) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Crocs, Inc. trades at $114.98 (market cap $5.60B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 4.5× Crocs, Inc.'s market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crocs, Inc. for 96 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| CROX | RPRX | |
|---|---|---|
Market Cap | $5.60B | $25.27B |
Volume | 1,026,773 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $141.19 | $63.96 |
52-Week Low | $73.39 | $35.44 |
Typical Hold Time | 96 Days | 1 Days |
Enterprise Value | $7.12B | $32.50B |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Crocs (CROX) trades at $116.84, up 1.42% with bearish technical signals but strong fundamentals including a low P/E of 10.37 and robust ROE of 42.3%. Recent earnings beats and a $136.78 analyst price target suggest upside potential despite negative net income in 2025. The company maintains solid cash flow generation and brand innovation focus.
The outlook remains positive with earnings momentum and valuation appeal, though risks include consumer spending volatility and HEYDUDE brand integration challenges. Analyst consensus leans bullish with 51% buy ratings, supporting potential recovery from current levels if execution improves.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
